{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "51407-918",
      "generic_name": "Bexagliflozin",
      "labeler_name": "Golden State Medical Supply, Inc.",
      "brand_name": "Bexagliflozin",
      "active_ingredients": [
        {
          "name": "BEXAGLIFLOZIN",
          "strength": "20 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "51407-918-30",
          "description": "30 TABLET in 1 BOTTLE (51407-918-30)",
          "marketing_start_date": "20240606",
          "sample": false
        },
        {
          "package_ndc": "51407-918-90",
          "description": "90 TABLET in 1 BOTTLE (51407-918-90)",
          "marketing_start_date": "20240606",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Golden State Medical Supply, Inc."
        ],
        "rxcui": [
          "2637859"
        ],
        "spl_set_id": [
          "1a3ba9d5-1009-bad0-e063-6294a90ac4cc"
        ],
        "nui": [
          "N0000187059",
          "N0000187058"
        ],
        "pharm_class_epc": [
          "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Sodium-Glucose Transporter 2 Inhibitors [MoA]"
        ],
        "unii": [
          "EY00JF42FV"
        ]
      },
      "marketing_category": "NDA AUTHORIZED GENERIC",
      "dosage_form": "TABLET",
      "spl_id": "57d77a92-1e20-5a1c-e063-6394a90ae710",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20230120",
      "product_id": "51407-918_57d77a92-1e20-5a1c-e063-6394a90ae710",
      "application_number": "NDA214373",
      "brand_name_base": "Bexagliflozin",
      "pharm_class": [
        "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]",
        "Sodium-Glucose Transporter 2 Inhibitors [MoA]"
      ]
    }
  ]
}